The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 04, 2026
Filed:
Nov. 06, 2024
Applicants:
City of Hope, Duarte, CA (US);
Imugene Limited, Sydney, AU;
Inventors:
Saul J. Priceman, Valley Village, CA (US);
Anthony K. Park, Pomona, CA (US);
Yuman Fong, Pasadena, CA (US);
Monil Shah, Sydney, AU;
Assignees:
City of Hope, Duarte, CA (US);
Imugene Limited, Sydney, AU;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61P 35/00 (2006.01); A61K 35/768 (2015.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); C07K 14/705 (2006.01); C07K 16/28 (2006.01); C07K 16/32 (2006.01); C12N 15/86 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); A61K 39/001112 (2018.08); A61K 39/39541 (2013.01); A61K 39/39558 (2013.01); A61P 35/00 (2018.01); C07K 14/70503 (2013.01); C07K 16/2803 (2013.01); C07K 16/2809 (2013.01); A61K 2039/505 (2013.01); A61K 2039/5256 (2013.01); C07K 2317/31 (2013.01); C12N 2710/24143 (2013.01); C12N 2710/24171 (2013.01);
Abstract
Described herein, inter alia, are oncolytic viruses expressing a truncated human CD19 (CD19t) and methods for treating a patient suffering from a solid tumor by administering an oncolytic virus expressing truncated human CD19 (OV19t), and optionally a T cell engager targeted to CD19.